发明名称 |
Treatment of cancer with TOR kinase inhibitors |
摘要 |
Provided herein are methods for treating or preventing a solid tumor, non-Hodgkin lymphoma or multiple myeloma in a patient, comprising administering an effective amount of a TOR kinase inhibitor to a patient having a solid tumor, non-Hodgkin lymphoma or multiple myeloma. |
申请公布号 |
US9493466(B2) |
申请公布日期 |
2016.11.15 |
申请号 |
US201213654441 |
申请日期 |
2012.10.18 |
申请人 |
Signal Pharmaceuticals, LLC |
发明人 |
Xu Shuichan;Hege Kristen Mae;Lopez-Girona Antonia;Raymon Heather;Narla Rama K.;Chopra Rajesh |
分类号 |
A01N43/58;A01N43/60;A61K31/50;A61K31/495;A61K38/00;A61P35/00;C07D487/04;A61K31/4166;A61K31/4188;A61K31/4985;C07D471/04;C07D473/00;C07D498/04 |
主分类号 |
A01N43/58 |
代理机构 |
Jones Day |
代理人 |
Jones Day |
主权项 |
1. A method for treating a solid tumor, comprising administering an effective amount of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-(trans-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, to a patient having a solid tumor, wherein the solid tumor is non-small cell lung cancer or breast cancer, and wherein the solid tumor is rapamycin resistant. |
地址 |
San Diego CA US |